-
2061
-
2062
Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor—Ivacaftor
Published 2023-03-01Get full text
Article -
2063
-
2064
-
2065
Efficacy of mucus regulation therapy in acute sinusitis
Published 2013-12-01“…In 2007, the European Academy of Allergology and Clinical Immunology (EAACI) and the European Rhinologic Society (ERS) signed the fundamental document that contains the guidelines for the treatment of rhinosinusitis and nasal polyps - the EPOS (European Position Paper on Rhinosinusitis and Nasal Polyposis). …”
Get full text
Article -
2066
Microbiome and Probiotics in Acne Vulgaris—A Narrative Review
Published 2022-03-01Get full text
Article -
2067
Long-Term Sustained Disease Control with Immunotherapy in Chemotherapy-Refractory Merkel Cell Carcinoma
Published 2019-09-01Get full text
Article -
2068
-
2069
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
Published 2021-01-01Get full text
Article -
2070
Estudio descriptivo de una cohorte de pacientes con COVID-19 hospitalizados en España
Published 2021-01-01Get full text
Article -
2071
Research advances in the role of interferon regulatory factor 4(IRF4) in chronic inflammatory diseases
Published 2022-07-01Get full text
Article -
2072
-
2073
Attitude of the Lithuanian Public toward Medical Assistance in Dying: A Cross-Sectional Study
Published 2024-03-01Get full text
Article -
2074
-
2075
-
2076
-
2077
Immune-based, multifaceted inactivation of pathogenic T lymphocytes in treating autoimmune diseases
Published 2023-10-01Get full text
Article -
2078
-
2079
-
2080
Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021
Published 2022-12-01Get full text
Article